ADME Toxicology Testing Market, Share & Trends Analysis Report, By Type of Services (Absorption, Distribution, Metabolism, Excretion), Type of Assays (Batch / Fed-Batch, Continuous), Type of Molecule (Biologics, Small Molecules), End User, Therapeutic Areas, By Region, and Segment Forecasts, 2024-2031

Report Id: 2596 Pages: 170 Last Updated: 22 October 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of ADME Toxicology Testing Market

Global ADME Toxicology Testing Market -Type of Services          

  • Absorption
  • Distribution
  • Metabolism
  • Excretion

ADME

Global ADME Toxicology Testing Market – Type of Assays          

  • Batch / Fed-Batch
  • Continuous

Global ADME Toxicology Testing Market – Type of Molecules          

  • Biologics
  • Small Molecules

Global ADME Toxicology Testing Market – End Users       

  • Pharmaceutical and Biotechnology Companies
  • Academic / Research Institutes

Global ADME Toxicology Testing Market – Therapeutic Areas          

  • Blood Disorder
  • Cardiovascular Disorder
  • Gastrointestinal and Vascular Disorder
  • Hormonal Disorder
  • Infectious Diseases
  • Immunological Disorders
  • Mental Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Respiratory Disorders

Global ADME Toxicology Testing Market – By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary

Chapter 3. Global ADME Toxicology Testing Market Snapshot

Chapter 4. Global ADME Toxicology Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: Type of Services Estimates & Trend Analysis
5.1. Type of Services & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Services:

5.2.1. Absorption
5.2.2. Distribution
5.2.3. Metabolism
5.2.4. Excretion

Chapter 6. Market Segmentation 2: Type of Assays Estimates & Trend Analysis
6.1. Type of Assays & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Assays:

6.2.1. Batch / Fed-Batch
6.2.2. Continuous

Chapter 7. Market Segmentation 3: Type of Molecules Estimates & Trend Analysis
7.1. Type of Molecules & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Molecules:

7.2.1. Biologics
7.2.2. Small Molecules

Chapter 8. Market Segmentation 4: End Users Estimates & Trend Analysis
8.1. End Users & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following End Users:

8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Academic / Research Institutes

Chapter 9. Market Segmentation 5: Therapeutic Areas Estimates & Trend Analysis
9.1. Therapeutic Areas & Market Share, 2019 & 2031
Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Therapeutic Areas:

9.1.1. Blood Disorder
9.1.2. Cardiovascular Disorder
9.1.3. Gastrointestinal and Vascular Disorder
9.1.4. Hormonal Disorder
9.1.5. Infectious Diseases
9.1.6. Immunological Disorders
9.1.7. Mental Disorders
9.1.8. Metabolic Disorders
9.1.9. Neurological Disorders
9.1.10. Oncology Disorders
9.1.11. Respiratory Disorders

Chapter 10. ADME Toxicology Testing Market Segmentation 4: Regional Estimates & Trend Analysis

10.1. North America
10.1.1. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.1.2. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.1.3. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.1.4. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.1.5. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.1.6. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.2. Europe
10.2.1. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.2.2. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.2.3. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.2.4. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.2.5. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.2.6. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts xx6, 2024-2031
10.2.7. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.3. Asia Pacific
10.3.1. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.3.2. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.3.3. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.3.4. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.3.5. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.3.6. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.4. Latin America
10.4.1. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.4.2. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.4.3. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.4.4. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.4.5. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.4.6. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

10.5. Middle East & Africa
10.5.1. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.5.2. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.5.3. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.5.4. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.5.5. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Therapeutic Areas, 2024-2031
10.5.6. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles

11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Promega Corporation
11.2.3. Agilent Technologies, Inc.
11.2.4. Charles River Laboratories
11.2.5. RTI International
11.2.6. Eurofins Scientific
11.2.7. Evotec
11.2.8. Galapagos
11.2.9. Tecan Group

11.2.10. GVK Biosciences
11.2.11. Pharmaron
11.2.12. Pharmaceutical Product Development (PPD)
11.2.13. Sai Life Sciences
11.2.14. Shanghai Medicilon
11.2.15. Syngene International
11.2.16. WuXi AppTec

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1451
Security Code field cannot be blank!

Frequently Asked Questions

The ADME Toxicology Testing Market Size is valued at USD 3.82 Bn in 2023 and is predicted to reach USD 7.12 Bn by the year 2031

The ADME Toxicology Testing Market is expected to grow at an 8.3% CAGR during the forecast period for 2024-2031.

Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies, Inc., Charles River Laboratories, RTI International., Eurofins Scientific, E

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying